pharmaceuticals

Image for Novo Nordisk cuts Wegovy price in South Africa for a second timeFinance

Novo Nordisk Cuts Wegovy Price in South Africa for a Second Time

Image for Analysis-TrumpRx lists many medicines at prices higher than paid in UKFinance

Analysis-TrumpRx Lists Many Medicines at Prices Higher Than Paid in UK

Image for Roche ramps up AI computing capacity with Nvidia chip expansionFinance

Roche Ramps up AI Computing Capacity With Nvidia Chip Expansion

Image for Brazil drugmaker EMS eyes overseas deals after buying Sanofi unitFinance

Brazil Drugmaker Ems Eyes Overseas Deals After Buying Sanofi Unit

Image for Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

Novo Nordisk Strikes Deal for Hims to Sell Wegovy and Ozempic, Drops Lawsuit

Date: March 9, 2026

COPENHAGEN, March 9 (Reuters) - Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' platform, the Danish drugmaker said on Monday,...

Image for Roche shares drop as oral breast cancer drug fails in trial

Roche Shares Drop as Oral Breast Cancer Drug Fails in Trial

Date: March 9, 2026

FRANKFURT, March 9 (Reuters) - Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker failed to show that its promising drug candidate giredestrant against a common form of breast...

Image for GSK licenses liver disease drug to Italy's Alfasigma for up to $690 million

Gsk Licenses Liver Disease Drug to Italy's Alfasigma for up to $690 Million

Date: March 9, 2026

March 9 (Reuters) - GSK said on Monday it will receive up to $690 million from Italian pharmaceutical company Alfasigma for the worldwide rights to linerixibat, an experimental treatment for severe...

Image for Galderma gives better than expected 2026 guidance, shares rise

Galderma Gives Better Than Expected 2026 Guidance, Shares Rise

Date: March 5, 2026

March 5 (Reuters) - Shares of Swiss skincare company Galderma opened higher on Thursday after it reported 17.7% growth in full-year net sales and gave an upbeat guidance for 2026.  The annual net...

Image for Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 billion

Sino Biopharm Unit Licenses Blood Cancer Drug to Sanofi for up to $1.53 Billion

Date: March 3, 2026

March 4 (Reuters) - Hong Kong-listed Sino Biopharmaceutical said on Wednesday its unit has signed an exclusive global licensing deal with French drugmaker Sanofi worth up to $1.53 billion, giving the...

Image for Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports

Hims' Pharmacy Partner Will Reintroduce GLP-1 Pill Pulled From Market, Endpoints News Reports

Date: March 3, 2026

March 3 (Reuters) - Hims & Hers Health's pharmacy partner, Strive Pharmacy, plans to resume sales of its compounded weight‑loss pill through other healthcare providers after halting distribution...